When should we consider chronic patients as non-responders to monoclonal antibodies targeting the CGRP pathway?
Claudia AltamuraSabina CevoliNicoletta BrunelliCinzia AuriliaLuisa FofiGabriella EgeoBarbanti PieroFabrizio Vernierinull nullPublished in: Journal of neurology (2021)